APOBEC3C and central nervous system cancer: Analysis of the CGGA database revealed that APOBEC3C expression was positively correlated with glioma WHO grade (Figure 2C), elevated in samples lacking 1p/19q codeletion (Figure 2D), and higher in IDH wild‐type patients (Figure 2F).